Fig. 5From: Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE studyTreatment exposure. n, number of patients with observation period equal or longer than 12 months (Safety set); OCT, optical coherence tomography; VA, visual acuityBack to article page